Sumeyra Derin

Cerrahpasa, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.

Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study.

Journal: Journal of chemotherapy (Florence, Italy)

Published: June 21, 2024

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.

Journal: The oncologist

Published: August 04, 2023

A case report of Wernicke Korsakoff syndrome in a patient with cholangiocellular carcinoma: An underestimated cause of encephalopathy in cancer patients.

A case report of Wernicke Korsakoff syndrome in a patient with cholangiocellular carcinoma: An underestimated cause of encephalopathy in cancer patients.

Journal: Medicine

Published: December 09, 2022

Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy.

Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy.

Journal: Journal of chemotherapy (Florence, Italy)

Published: February 28, 2022

Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme.

Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: December 08, 2021

The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience.

The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience.

Journal: Journal of medical virology

Published: April 16, 2021

Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency.

Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: October 12, 2020

A single center's experience of the extrapulmonary neuroendocrine carcinomas.

A single center's experience of the extrapulmonary neuroendocrine carcinomas.

Journal: Northern clinics of Istanbul

Published: October 07, 2020

Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer.

Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer.

Journal: Tumori

Published: September 16, 2020

Loss of skeletal muscle area and fat-free mass during dabrafenib/trametinib and vemurafenib/cobimetinib treatments in patients with BRAF-mutant metastatic malignant melanoma.

Loss of skeletal muscle area and fat-free mass during dabrafenib/trametinib and vemurafenib/cobimetinib treatments in patients with BRAF-mutant metastatic malignant melanoma.

Journal: Melanoma research

Published: September 08, 2020

Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer.

Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: December 02, 2019

Biweekly cisplatin and gemcitabine with two different doses in non small cell lung cancer patients: A retrospective singlecenter experience.

Biweekly cisplatin and gemcitabine with two different doses in non small cell lung cancer patients: A retrospective singlecenter experience.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: October 26, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026